Hayek Kallen Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-64,482
| Closed | -$2.14M | – | 68 |
|
|
2017
Q2 | $2.14M | Sell |
64,482
-1,019
| -2% | -$33.9K | 1.45% | 32 |
|
|
2017
Q1 | $2.1M | Sell |
65,501
-938
| -1% | -$30.1K | 1.46% | 31 |
|
|
2016
Q4 | $2.41M | Sell |
66,439
-5,428
| -8% | -$197K | 1.75% | 28 |
|
|
2016
Q3 | $3.31M | Buy |
71,867
+1,381
| +2% | +$63.5K | 2.36% | 19 |
|
|
2016
Q2 | $3.54M | Buy |
70,486
+3,251
| +5% | +$163K | 2.54% | 19 |
|
|
2016
Q1 | $3.6M | Sell |
67,235
-399
| -0.6% | -$21.4K | 2.67% | 16 |
|
|
2015
Q4 | $4.44M | Sell |
67,634
-1,749
| -3% | -$115K | 3.4% | 10 |
|
|
2015
Q3 | $3.92M | Sell |
69,383
-5,729
| -8% | -$323K | 3.05% | 13 |
|
|
2015
Q2 | $4.44M | Buy |
75,112
+681
| +0.9% | +$40.2K | 3.32% | 10 |
|
|
2015
Q1 | $4.64M | Sell |
74,431
-1,260
| -2% | -$78.5K | 3.42% | 10 |
|
|
2014
Q4 | $4.35M | Sell |
75,691
-2,135
| -3% | -$123K | 3.22% | 13 |
|
|
2014
Q3 | $4.18M | Sell |
77,826
-1,250
| -2% | -$67.2K | 3.18% | 13 |
|
|
2014
Q2 | $4.15M | Sell |
79,076
-1,148
| -1% | -$60.2K | 3.13% | 13 |
|
|
2014
Q1 | $4.24M | Sell |
80,224
-2,147
| -3% | -$113K | 3.38% | 10 |
|
|
2013
Q4 | $3.3M | Sell |
82,371
-1,748
| -2% | -$70.1K | 2.57% | 19 |
|
|
2013
Q3 | $3.18M | Sell |
84,119
-4,022
| -5% | -$152K | 2.63% | 17 |
|
|
2013
Q2 | $3.46M | Buy |
+88,141
| New | +$3.46M | 2.92% | 14 |
|